Disc Medicine (NASDAQ:IRON) Earns “Buy” Rating from HC Wainwright
Disc Medicine (NASDAQ:IRON – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at HC Wainwright in a research report issued on Tuesday,Benzinga reports. They currently have a $118.00 price target on the stock. HC Wainwright’s target price suggests a potential upside of 135.58% from the stock’s previous close. IRON has […]
Disc Medicine (NASDAQ:IRON – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at HC Wainwright in a research report issued on Tuesday,Benzinga reports. They currently have a $118.00 price target on the stock. HC Wainwright’s target price suggests a potential upside of 135.58% from the stock’s previous close. IRON has […]
-limited-logo-1200x675.png?v=20220228095611&w=240&h=240&zc=2){kind=logo}
